A pharmacological approach to outpatient benzodiazepine detoxification.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001463:Barbiturates / Q000494:pharmacology; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008140:Lorazepam / Q000009:adverse effects; D008297:Male; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D010634:Phenobarbital / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000628:therapy*
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D008140:Lorazepam; D010634:Phenobarbital